in this issue
Regions :: Western Europe
AbbVie to acquire Shire for $55 billion
1:12 PM MDT | July 18, 2014 | Natasha Alperowicz
The boards of AbbVie (North Chicago, IL) and Shire (Dublin) announced today that they have reached agreement for AbbVie to acquire Shire for approximately £32 billion ($54.7 billion). The price represents a premium of approximately 53% to the price of Shire shares on 2 May, the last business day prior to AbbVie’s initial proposal. The companies say that the transaction will create a well-positioned specialty biopharmaceutical company with sustainable leadership positions within areas of unmet need, including immunology, rare diseases, neuroscience...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee